The Clinical Dementia Rating (CDR) is a widely used tool to assess the severity of dementia, including Alzheimer's disease. It evaluates cognitive and functional impairments across six domains: memory, orientation, judgment and problem-solving, community affairs, home and hobbies, and personal care. The CDR scale categorizes individuals into five stages: 0 (no impairment), 0.5 (questionable impairment), 1 (mild), 2 (moderate), and 3 (severe dementia). This structured approach helps clinicians and researchers standardize the assessment of dementia progression and tailor appropriate care plans. By systematically evaluating both cognitive decline and functional abilities, the CDR provides valuable insights into disease severity and helps track changes over time, crucial for understanding the impact of Alzheimer's and other forms of dementia on individuals and guiding clinical interventions.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States